• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Swelling/ Edema (4577)
Event Date 10/04/2022
Event Type  Injury  
Manufacturer Narrative
This is a definitive report.This case was reported from a physician.According to the physician, it was considered that artz dispo was definitely related because her living practice including food, life, and other medicines was not changed other than artz dispo injection and she had swelling face when she received 1st injection of artz dispo.Company comment: it was considered that the swelling face and face edema was probably related to artz dispo because other factors such as physical condition due to aging could be affected.
 
Event Description
(b)(6) 2022 - at 14:30, an 85 year-old female patient received 1st injection of artz dispo for left gonarthrosis.She had discomfort on her face from the evening.At 19:00, she had swelling face and face edema.2022-10-05 - in the morning, she had swelling face to the extent that she couldn't open her eyelids.She visited this clinic and was admitted.The physician prescribed 100 mg hydrocortone injection (hydrocortisone sodium phosphate) with saline, 25 mg atarax-p parenteral solution (hydroxyzine hydrochloride).Administration of 20 mg predonine (prednisolone) and 120mg allegra (fexofenadine hydrochloride) started.(b)(6) 2022 - she recovered and administration of 20 mg predonine was terminated.(b)(6) 2022- administration of 120 mg allegra was terminated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318-0 001
JA   318-0001
Manufacturer Contact
pharmacovigilance dept
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
JA   100-0005
MDR Report Key15711943
MDR Text Key302829281
Report Number9612392-2022-00007
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 10/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/05/2022
Initial Date FDA Received11/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age85 YR
Patient SexFemale
-
-